iShares MSCI World Health Care Sector Advanced UCITS ETF (LON:WHCA)

Assets	340.16M
Expense Ratio	0.18%
PE Ratio	23.16
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+18.84%

Volume	71,632
Open	4.422
Previous Close	4.393
Day's Range	4.387 - 4.446
52-Week Low	3.685
52-Week High	4.547
Beta	n/a
Holdings	130
Inception Date	Nov 3, 2021

About WHCA

iShares MSCI World Health Care Sector Advanced UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in public equity markets of developed countries across the globe. It seeks to invest in the stocks of companies operating in the health care sector, which include companies which manufacture health care equipment and supplies or provide health care related services, including distributors of health care products, providers of basic health-care services, and owners and operators of health care facilities and organizations, and companies involved in the research, development, production and marketing of pharmaceuticals and biotechnology products. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI World Health Care Index Net USD, by investing in the stocks of companies as per their weightings in the index. iShares MSCI World Health Care Sector Advanced UCITS ETF was formed on August 19, 2011 and is domiciled in Ireland.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: London Stock Exchange
• Ticker Symbol: WHCA
• Provider: iShares
• Index Tracked: MSCI World Health Care Advanced Select 20 35 Capped Index - USD - Benchmark TR Net

Performance

WHCA had a total return of 18.84% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.31%.

Top 10 Holdings

46.42% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.70%
Johnson & Johnson	JNJ	6.29%
AbbVie Inc.	ABBV	5.74%
Novartis AG	NOVN	4.90%
Merck & Co., Inc.	MRK	3.79%
Roche Holding AG	ROP	3.68%
UnitedHealth Group Incorporated	UNH	3.64%
AstraZeneca PLC	AZN	2.88%
Gilead Sciences, Inc.	GILD	2.65%
Amgen Inc.	AMGN	2.16%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error